1. Academic Validation
  2. FAM65B controls the proliferation of transformed and primary T cells

FAM65B controls the proliferation of transformed and primary T cells

  • Oncotarget. 2016 Sep 27;7(39):63215-63225. doi: 10.18632/oncotarget.11438.
Jeanne Froehlich 1 2 3 Margaux Versapuech 1 2 3 Laura Megrelis 1 2 3 Quitterie Largeteau 1 2 3 Sylvain Meunier 4 Corinne Tanchot 4 Georges Bismuth 1 2 3 Jérôme Delon 1 2 3 Marianne Mangeney 1 2 3
Affiliations

Affiliations

  • 1 Inserm, Institut Cochin, Paris, France.
  • 2 Cnrs, Paris, France.
  • 3 Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • 4 Inserm, PARCC, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Abstract

Cell quiescence is controlled by regulated genome-encoded programs that actively express genes which are often down-regulated or inactivated in transformed cells. Among them is FoxO1, a transcription factor that imposes quiescence in several cell types, including T lymphocytes. In these cells, the FAM65B encoding gene is a major target of FOXO1. Here, we show that forced expression of FAM65B in transformed cells blocks their mitosis because of a defect of the mitotic spindle, leading to G2 cell cycle arrest and Apoptosis. Upon cell proliferation arrest, FAM65B is engaged in a complex containing two proteins well known to be involved in cell proliferation i.e. the HDAC6 deacetylase and the 14.3.3 scaffolding protein. In primary T cells, FAM65B is down-regulated upon T cell receptor engagement, and maintaining its expression blocks their proliferation, establishing that the decrease of FAM65B expression is required for proliferation. Conversely, inhibiting FAM65B expression in naive T lymphocytes decreases their activation threshold. These results identify FAM65B as a potential new target for controlling proliferation of both transformed and normal cells.

Keywords

T lymphocytes; cell cycle; cell proliferation; leukemia; signaling.

Figures